“We’re [going to] have a whole new era of immune therapies and different novel ways to treat [patients], and then [utilize] combinations of these therapies,” says Michael S. Cookson, MD, MMHC, FACS.
In this video, the Society of Urologic Oncology’s (SUO) Past President Michael S. Cookson, MD, MMHC, FACS, discusses general advancements in genitourinary cancer that were presented at the 2021 SUO Annual Meeting. Cookson is a professor and the Donald D. Albers endowed chair in urology at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.
Enhancing the quality of bladder cancer care in the community setting
August 5th 2023Suzanne Merrill, MD, recaps the BCAN 2023 Think Tank session she co-chaired that covered prehabilitation programs, urinary diversion management, and other focal areas aimed at enhancing the quality of bladder cancer care in the community.
BCAN session to highlight epigenetics and response to immunotherapy in bladder cancer
August 3rd 2023"I'm really optimistic that the session we are conducting will provide some recommendations [and] some ideas that will help us think about utilizing epigenetic therapies in a very evidence-based way," says Ania Woloszynska, PhD.
2 Clarke Drive
Cranbury, NJ 08512